Mobile Units Cut Deaths Among Drug Users
An NIH-funded trial found integrated mobile medical services sharply reduced all-cause deaths among adults who inject drugs.
Updated on Nov. 4, 2026 in Substance Abuse
A National Institutes of Health-funded trial, HPTN 094, found that mobile medical units offering integrated services reduced all-cause deaths by 71% among people who inject drugs. The study enrolled 409 adults without HIV who had opioid use disorder across five U.S. cities.
Why it matters
The results suggest that delivering prevention and treatment directly through mobile units may protect a high-risk population more effectively than referring them to community services alone. Researchers state that replication is still needed before the approach can be broadly adopted.
The trial compared outcomes across 409 adults without HIV who injected drugs, with 71% lower all-cause mortality in the mobile unit arm than the comparison arm after 26 weeks of intervention. Only 14% of participants were using medication for opioid use disorder at 26 and 52 weeks, and the study does not yet establish whether the mortality gap will persist with replication.
The players
National Institutes of Health
The NIH is the principal U.S. federal agency for biomedical and health research, and it funded the HPTN 094 trial.
The details
Participants in the mobile unit arm received peer navigation plus integrated PrEP, medication for opioid use disorder, and limited clinical and supportive services delivered on a mobile unit. The comparison arm received peer navigation linking them to available non-mobile community services, and the two groups showed no difference in use of daily oral PrEP or medication for opioid use disorder.
Timeline
Trial intervention ran for 26 weeks, with outcomes measured at 26 and 52 weeks.
NIH published the HPTN 094 results on November 4, 2026.
Health Landscape
The HPTN 094 trial extends the NIH-sponsored HPTN network's HIV prevention research into people who inject drugs, testing service delivery rather than a single drug. It shifts attention toward integrated care models for populations that have been difficult to reach with conventional clinic-based prevention.
For people who inject drugs, mobile units offering integrated HIV prevention and treatment may provide services closer to where they live than traditional clinics. Individuals currently using drugs can ask local health providers whether PrEP and medication for opioid use disorder are available through outreach programs.
The takeaway
Mobile, integrated services may be one way to reach people who inject drugs when clinic-based care is hard to access. Replication studies will determine whether these results hold across other settings.
Further reading
Explore more on Substance Abuse coverage across the United States.
